Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Oncology|April 15, 2000
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.Breast Cancer Research and Treatment|May 20, 2011
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancerE Razis, M Bobos, V Kotoula, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology GroupA Bamias, G Aravantinos, C Deliveliotis, et al.Breast Cancer Research and Treatment|May 18, 2020
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancerA Koumarianou, P Makrantonakis, F Zagouri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2005
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II studyH P Kalofonos, G Aravantinos, P Kosmidis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.British Journal of Cancer|November 6, 2008
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyA K Koutras, K T Kalogeras, M-A Dimopoulos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)A Bamias, U Dafni, A Karadimou, et al.Breast Cancer Research and Treatment|May 17, 2008
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, U Dafni, M A Dimopoulos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, U Dafni, et al.Pageof 9